⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MYGN News
Myriad Genetics Inc
Genetic Testing Market Size to Surge to USD 62.61 Billion by 2035 – SNS Insider
globenewswire.com
ILMN
MYGN
TMO
NTRA
GH
INV
ABT
DGX
LH
CLRS
Myriad Genetics to Present at 2026 Wells Fargo Healthcare Conference
globenewswire.com
MYGN
Bronstein, Gewirtz & Grossman, LLC Encourages Myriad Genetics, Inc. (MYGN) Shareholders to Inquire about Securities Investigation
accessnewswire.com
MYGN
Bronstein, Gewirtz & Grossman, LLC Is Investigating Myriad Genetics, Inc. (MYGN) And Encourages Shareholders to Connect
accessnewswire.com
MYGN
Molecular Diagnostics Market to Grow from USD 19.48 Billion in 2025 to USD 30.74 Billion by 2030, at a CAGR of 9.6% - MarketsandMarkets™
globenewswire.com
DHR
ILMN
HOLX
TMO
ABT
RIVN
DGX
MYGN
EXAS
BDX
BRKR
MYGN INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Myriad Genetics Inc.
accessnewswire.com
MYGN
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Myriad Genetics, Inc. (MYGN) And Encourages Shareholders to Reach Out
accessnewswire.com
MYGN
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Myriad Genetics, Inc. (MYGN) and Encourages Shareholders to Learn More About the Investigation
accessnewswire.com
MYGN
Cancer Diagnostics Market worth $44.92 billion by 2031 - Exclusive Report by MarketsandMarkets™
prnewswire.com
DHR
TMO
ABT
ILMN
HOG
BDX
EXAS
MYGN
NEO
QGEN
PATH
Bronstein, Gewirtz & Grossman, LLC Encourages Myriad Genetics, Inc. (MYGN) Stockholders to Inquire about Securities Investigation
accessnewswire.com
MYGN